Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Folic acid reduces doxorubicin-induced cardiomyopathy by modulating endothelial nitric oxide synthase.

Octavia Y, Kararigas G, de Boer M, Chrifi I, Kietadisorn R, Swinnen M, Duimel H, Verheyen FK, Brandt MM, Fliegner D, Cheng C, Janssens S, Duncker DJ, Moens AL.

J Cell Mol Med. 2017 Dec;21(12):3277-3287. doi: 10.1111/jcmm.13231. Epub 2017 Jun 13.

2.

Sustained Placental Growth Factor-2 Treatment Does Not Aggravate Advanced Atherosclerosis in Ischemic Cardiomyopathy.

Wu M, Pokreisz P, Swinnen M, Caluwe E, Gillijns H, Vanden Driessche N, Casazza A, Verbeken E, Collen D, Janssens S.

J Cardiovasc Transl Res. 2017 Aug;10(4):348-358. doi: 10.1007/s12265-017-9742-4. Epub 2017 Apr 10.

PMID:
28397162
3.

Antioxidant Treatment Improves Cardiac Dysfunction in a Murine Model of Premature Aging.

Hemmeryckx B, Hohensinner P, Swinnen M, Heggermont W, Wojta J, Lijnen HR.

J Cardiovasc Pharmacol. 2016 Nov;68(5):374-382.

PMID:
27824722
4.

Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.

Vandenwijngaert S, Swinnen M, Walravens AS, Beerens M, Gillijns H, Caluwé E, Tainsh RE, Nathan DI, Allen K, Brouckaert P, Bartunek J, Scherrer-Crosbie M, Bloch KD, Bloch DB, Janssens SP, Buys ES.

Antioxid Redox Signal. 2017 Feb 1;26(4):153-164. doi: 10.1089/ars.2015.6542. Epub 2016 Sep 8.

5.

Concomitant Phosphodiesterase 5 Inhibition Enhances Myocardial Protection by Inhaled Nitric Oxide in Ischemia-Reperfusion Injury.

Lux A, Pokreisz P, Swinnen M, Caluwe E, Gillijns H, Szelid Z, Merkely B, Janssens SP.

J Pharmacol Exp Ther. 2016 Feb;356(2):284-92. doi: 10.1124/jpet.115.227850. Epub 2015 Nov 30.

PMID:
26621143
6.

Mesodermal iPSC-derived progenitor cells functionally regenerate cardiac and skeletal muscle.

Quattrocelli M, Swinnen M, Giacomazzi G, Camps J, Barthélemy I, Ceccarelli G, Caluwé E, Grosemans H, Thorrez L, Pelizzo G, Muijtjens M, Verfaillie CM, Blot S, Janssens S, Sampaolesi M.

J Clin Invest. 2015 Dec;125(12):4463-82. doi: 10.1172/JCI82735. Epub 2015 Nov 16.

7.

Meox2/Tcf15 heterodimers program the heart capillary endothelium for cardiac fatty acid uptake.

Coppiello G, Collantes M, Sirerol-Piquer MS, Vandenwijngaert S, Schoors S, Swinnen M, Vandersmissen I, Herijgers P, Topal B, van Loon J, Goffin J, Prósper F, Carmeliet P, García-Verdugo JM, Janssens S, Peñuelas I, Aranguren XL, Luttun A.

Circulation. 2015 Mar 3;131(9):815-26. doi: 10.1161/CIRCULATIONAHA.114.013721. Epub 2015 Jan 5.

PMID:
25561514
8.

Osteoglycin prevents cardiac dilatation and dysfunction after myocardial infarction through infarct collagen strengthening.

Van Aelst LN, Voss S, Carai P, Van Leeuwen R, Vanhoutte D, Sanders-van Wijk S, Eurlings L, Swinnen M, Verheyen FK, Verbeken E, Nef H, Troidl C, Cook SA, Brunner-La Rocca HP, Möllmann H, Papageorgiou AP, Heymans S.

Circ Res. 2015 Jan 30;116(3):425-36. doi: 10.1161/CIRCRESAHA.116.304599. Epub 2014 Dec 17.

PMID:
25520363
9.

Murine pressure overload models: a 30-MHz look brings a whole new "sound" into data interpretation.

Hermans H, Swinnen M, Pokreisz P, Caluwé E, Dymarkowski S, Herregods MC, Janssens S, Herijgers P.

J Appl Physiol (1985). 2014 Sep 1;117(5):563-71. doi: 10.1152/japplphysiol.00363.2014. Epub 2014 Jul 24.

10.

Effect of sitagliptin treatment on metabolism and cardiac function in genetic diabetic mice.

Hemmeryckx B, Swinnen M, Gallacher DJ, Rong Lu H, Roger Lijnen H.

Eur J Pharmacol. 2014 Jan 15;723:175-80. doi: 10.1016/j.ejphar.2013.12.036. Epub 2014 Jan 6.

PMID:
24406339
11.

Atrial natriuretic peptide is negatively regulated by microRNA-425.

Arora P, Wu C, Khan AM, Bloch DB, Davis-Dusenbery BN, Ghorbani A, Spagnolli E, Martinez A, Ryan A, Tainsh LT, Kim S, Rong J, Huan T, Freedman JE, Levy D, Miller KK, Hata A, Del Monte F, Vandenwijngaert S, Swinnen M, Janssens S, Holmes TM, Buys ES, Bloch KD, Newton-Cheh C, Wang TJ.

J Clin Invest. 2013 Aug;123(8):3378-82. doi: 10.1172/JCI67383. Epub 2013 Jul 15.

12.

Does rosiglitazone affect adiposity and cardiac function in genetic diabetic mice?

Hemmeryckx B, Hoylaerts MF, Gallacher DJ, Rong Lu H, Himmelreich U, D'hooge J, Swinnen M, Lijnen HR.

Eur J Pharmacol. 2013 Jan 30;700(1-3):23-31. doi: 10.1016/j.ejphar.2012.11.062. Epub 2012 Dec 7.

PMID:
23228931
13.

Repression of cardiac hypertrophy by KLF15: underlying mechanisms and therapeutic implications.

Leenders JJ, Wijnen WJ, van der Made I, Hiller M, Swinnen M, Vandendriessche T, Chuah M, Pinto YM, Creemers EE.

PLoS One. 2012;7(5):e36754. doi: 10.1371/journal.pone.0036754. Epub 2012 May 7.

14.

Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells.

Papageorgiou AP, Swinnen M, Vanhoutte D, VandenDriessche T, Chuah M, Lindner D, Verhesen W, de Vries B, D'hooge J, Lutgens E, Westermann D, Carmeliet P, Heymans S.

Cardiovasc Res. 2012 Apr 1;94(1):115-24. doi: 10.1093/cvr/cvs077. Epub 2012 Feb 2.

PMID:
22308237
15.

Absence of thrombospondin-2 increases cardiomyocyte damage and matrix disruption in doxorubicin-induced cardiomyopathy.

van Almen GC, Swinnen M, Carai P, Verhesen W, Cleutjens JP, D'hooge J, Verheyen FK, Pinto YM, Schroen B, Carmeliet P, Heymans S.

J Mol Cell Cardiol. 2011 Sep;51(3):318-28. doi: 10.1016/j.yjmcc.2011.05.010. Epub 2011 May 23.

PMID:
21624372
16.

MicroRNA-18 and microRNA-19 regulate CTGF and TSP-1 expression in age-related heart failure.

van Almen GC, Verhesen W, van Leeuwen RE, van de Vrie M, Eurlings C, Schellings MW, Swinnen M, Cleutjens JP, van Zandvoort MA, Heymans S, Schroen B.

Aging Cell. 2011 Oct;10(5):769-79. doi: 10.1111/j.1474-9726.2011.00714.x. Epub 2011 May 25.

17.

Syndecan-1 amplifies angiotensin II-induced cardiac fibrosis.

Schellings MW, Vanhoutte D, van Almen GC, Swinnen M, Leenders JJ, Kubben N, van Leeuwen RE, Hofstra L, Heymans S, Pinto YM.

Hypertension. 2010 Feb;55(2):249-56. doi: 10.1161/HYPERTENSIONAHA.109.137885. Epub 2010 Jan 4.

PMID:
20048198
18.

Absence of thrombospondin-2 causes age-related dilated cardiomyopathy.

Swinnen M, Vanhoutte D, Van Almen GC, Hamdani N, Schellings MW, D'hooge J, Van der Velden J, Weaver MS, Sage EH, Bornstein P, Verheyen FK, VandenDriessche T, Chuah MK, Westermann D, Paulus WJ, Van de Werf F, Schroen B, Carmeliet P, Pinto YM, Heymans S.

Circulation. 2009 Oct 20;120(16):1585-97. doi: 10.1161/CIRCULATIONAHA.109.863266. Epub 2009 Oct 5.

PMID:
19805649
19.

Inflammatory rather than infectious insults play a role in exocrine tissue damage in a mouse model for coxsackievirus B4-induced pancreatitis.

De Palma AM, Thibaut HJ, Li S, Van Aelst I, Dillen C, Swinnen M, Verbeken E, Neyts J, Opdenakker G.

J Pathol. 2009 Apr;217(5):633-41. doi: 10.1002/path.2501.

PMID:
19142976
20.

Absence of SPARC results in increased cardiac rupture and dysfunction after acute myocardial infarction.

Schellings MW, Vanhoutte D, Swinnen M, Cleutjens JP, Debets J, van Leeuwen RE, d'Hooge J, Van de Werf F, Carmeliet P, Pinto YM, Sage EH, Heymans S.

J Exp Med. 2009 Jan 16;206(1):113-23. doi: 10.1084/jem.20081244. Epub 2008 Dec 22.

21.

Nitric oxide inhalation improves microvascular flow and decreases infarction size after myocardial ischemia and reperfusion.

Liu X, Huang Y, Pokreisz P, Vermeersch P, Marsboom G, Swinnen M, Verbeken E, Santos J, Pellens M, Gillijns H, Van de Werf F, Bloch KD, Janssens S.

J Am Coll Cardiol. 2007 Aug 21;50(8):808-17. Epub 2007 Aug 6.

22.

Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.

Vermeersch P, Buys E, Pokreisz P, Marsboom G, Ichinose F, Sips P, Pellens M, Gillijns H, Swinnen M, Graveline A, Collen D, Dewerchin M, Brouckaert P, Bloch KD, Janssens S.

Circulation. 2007 Aug 21;116(8):936-43. Epub 2007 Aug 6.

PMID:
17679618
23.

Increased expression of syndecan-1 protects against cardiac dilatation and dysfunction after myocardial infarction.

Vanhoutte D, Schellings MW, Götte M, Swinnen M, Herias V, Wild MK, Vestweber D, Chorianopoulos E, Cortés V, Rigotti A, Stepp MA, Van de Werf F, Carmeliet P, Pinto YM, Heymans S.

Circulation. 2007 Jan 30;115(4):475-82. Epub 2007 Jan 22.

PMID:
17242279
24.

Inhibition of urokinase-type plasminogen activator or matrix metalloproteinases prevents cardiac injury and dysfunction during viral myocarditis.

Heymans S, Pauschinger M, De Palma A, Kallwellis-Opara A, Rutschow S, Swinnen M, Vanhoutte D, Gao F, Torpai R, Baker AH, Padalko E, Neyts J, Schultheiss HP, Van de Werf F, Carmeliet P, Pinto YM.

Circulation. 2006 Aug 8;114(6):565-73. Epub 2006 Jul 31.

PMID:
16880329
25.
26.

Purification and characterization of a 315 kDa keratinolytic subtilisin-like serine protease from Microsporum canis and evidence of its secretion in naturally infected cats.

Mignon B, Swinnen M, Bouchara JP, Hofinger M, Nikkels A, Pierard G, Gerday C, Losson B.

Med Mycol. 1998 Dec;36(6):395-404.

PMID:
10206750
27.

[Argon laser treatment of the iris: an experimental study (author's transl)].

Brihaye M, Vrensen G, Swinnen M, Verworst F, Peters O, Jäger M.

Klin Monbl Augenheilkd. 1982 Jan;180(1):65-7. German.

PMID:
7078000
28.

Argon laser lesions of the rabbit iris: quantitative aspects.

Vrensen G, Brihaye-van Geertruyden M, Willekens B, Mataw I, Swinnen M.

Graefes Arch Clin Exp Ophthalmol. 1982;219(2):80-91.

PMID:
6890497
29.

[Acute posterior placoid pigment epitheliopathy and central serous retinitis].

Swinnen MC, Brihaye-Van Geertruyden M, Fiévet JP.

Bull Soc Belge Ophtalmol. 1981;198(2):67-79. French. No abstract available.

PMID:
7052329
30.

[A case of heriditary arthro-ophthalmopathy: Stickler's syndrome].

Brihaye-Van Geertruyden M, Verlaeken L, Herzeel R, Swinnen MC, Malfroot A.

Bull Soc Belge Ophtalmol. 1979;183:143-7. French. No abstract available.

PMID:
526682
31.

High-performance colorimeter with an electronic bubble gate for use in miniaturized continuous-flow analyzers.

Neeley WE, Wardlaw SC, Yates T, Hollingsworth WG, Swinnen ME.

Clin Chem. 1976 Feb;22(2):227-31.

PMID:
1248125
32.

Design and operation of a signal comparator to increase efficiency of continuous-flow analyzers.

Neeley WE, Wardlaw S, Swinnen ME.

Clin Chem. 1974;20(1):78-80. No abstract available.

33.

The design of biomedical instrumentation made easy through the use of operational amplifiers.

Swinnen ME.

Psychophysiology. 1968 Sep;5(2):178-87. No abstract available.

PMID:
5683026
34.

A versatile programmer for ratio and interval schedules using a punched-tape reader.

Swinnen ME, Hodos W.

J Exp Anal Behav. 1967 Nov;10(6):515-6. No abstract available.

35.

An inexpensive level detector.

Swinnen ME.

Psychophysiology. 1967 Jan;3(3):318-20. No abstract available.

PMID:
6038678
36.

A novel peak detector.

Swinnen ME, Plumlee LA, Brown CC.

Psychophysiology. 1966 Jul;3(1):98-100. No abstract available.

PMID:
5942880
37.

A novel cardiotachometer.

Swinnen ME, Hamilton RD.

IEEE Trans Biomed Eng. 1966 Apr;13(2):100-1. No abstract available.

PMID:
5964783
38.

A pulse former for counter-printers.

Swinnen ME.

J Exp Anal Behav. 1966 Jan;9(1):27-8. No abstract available.

Supplemental Content

Loading ...
Support Center